Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls Lynda Schneider, MD, Adriana Weinberg, MD, Mark Boguniewicz, MD, Patricia Taylor, NP, Hans Oettgen, MD, PhD, Lisa Heughan, BS, Daniel Zaccaro, MS, Brian Armstrong, MPH, Aaron Holliday, BS, Donald Y.M. Leung, MD, PhD Journal of Allergy and Clinical Immunology Volume 126, Issue 6, Pages 1306-1307.e2 (December 2010) DOI: 10.1016/j.jaci.2010.08.010 Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 IFN-γ SFCs after VZV stimulation as measured by ELISPOT in controls versus subjects with AD. Journal of Allergy and Clinical Immunology 2010 126, 1306-1307.e2DOI: (10.1016/j.jaci.2010.08.010) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 2 Total IgE level (A), VZV-specific IgE (B), and VZV-specific IgG (C) in control subjects and subjects with AD without a history of EH (ADEH−) and with a history of EH (ADEH+). Journal of Allergy and Clinical Immunology 2010 126, 1306-1307.e2DOI: (10.1016/j.jaci.2010.08.010) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions
IFN-γ SFCs after PHA stimulation as measured by ELISPOT in controls versus subjects with AD. Journal of Allergy and Clinical Immunology 2010 126, 1306-1307.e2DOI: (10.1016/j.jaci.2010.08.010) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions